全文获取类型
收费全文 | 96810篇 |
免费 | 6597篇 |
国内免费 | 510篇 |
专业分类
耳鼻咽喉 | 1208篇 |
儿科学 | 2288篇 |
妇产科学 | 1385篇 |
基础医学 | 12435篇 |
口腔科学 | 2310篇 |
临床医学 | 9534篇 |
内科学 | 21332篇 |
皮肤病学 | 1518篇 |
神经病学 | 9229篇 |
特种医学 | 3949篇 |
外国民族医学 | 1篇 |
外科学 | 16059篇 |
综合类 | 800篇 |
一般理论 | 194篇 |
预防医学 | 6554篇 |
眼科学 | 1836篇 |
药学 | 5856篇 |
中国医学 | 139篇 |
肿瘤学 | 7290篇 |
出版年
2023年 | 864篇 |
2022年 | 1498篇 |
2021年 | 3287篇 |
2020年 | 1821篇 |
2019年 | 2822篇 |
2018年 | 3316篇 |
2017年 | 2350篇 |
2016年 | 2542篇 |
2015年 | 2859篇 |
2014年 | 3943篇 |
2013年 | 5048篇 |
2012年 | 7639篇 |
2011年 | 7739篇 |
2010年 | 4267篇 |
2009年 | 3704篇 |
2008年 | 6368篇 |
2007年 | 6141篇 |
2006年 | 5949篇 |
2005年 | 5865篇 |
2004年 | 5281篇 |
2003年 | 4846篇 |
2002年 | 4349篇 |
2001年 | 618篇 |
2000年 | 487篇 |
1999年 | 686篇 |
1998年 | 892篇 |
1997年 | 710篇 |
1996年 | 573篇 |
1995年 | 565篇 |
1994年 | 451篇 |
1993年 | 459篇 |
1992年 | 364篇 |
1991年 | 324篇 |
1990年 | 299篇 |
1989年 | 289篇 |
1988年 | 291篇 |
1987年 | 265篇 |
1986年 | 290篇 |
1985年 | 287篇 |
1984年 | 355篇 |
1983年 | 308篇 |
1982年 | 339篇 |
1981年 | 338篇 |
1980年 | 263篇 |
1979年 | 151篇 |
1978年 | 193篇 |
1977年 | 181篇 |
1976年 | 130篇 |
1975年 | 134篇 |
1974年 | 132篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
P. Baur V. Daniel S. Pomer H. Scheurlen G. Opelz D. Roelcke 《Annals of hematology》1991,62(2-3):68-73
Summary The hepatitis C-virus (HCV) is the main etiologic agent of posttransfusion hepatitis (PTH). Most patients depending on hemodialysis need transfusion of blood before kidney transplantation. Of 272 patients after kidney transplantation, 27 (10%) were found to be anti-HCV-ELISA-positive (HCV-Antibody-ELISA, Ortho Diagnostics). The antibodies could be neutralized by HCV C-100-3 antigen. Eight of 22 patients (36%) who had more than one kidney transplantation were classified anti-HCV positive [30% (8/27) of all anti-HCV positive patients]. The number of transfused blood units ranged from 0 to 99 BU. Receiving more than one kidney graft or the transfusion of more than 5 units of blood increased the risk for HCV infection 3.5 or 4.1 times, respectively, compared with one transplantation or less than 5 units of blood. No significant interactions were seen between these two variables. Of the anti-HCV positive patients, 48% were anti-HBc negative as well as HBs-antigen negative, 52% were anti-HBc positive.Abbreviations A492
absorbance at 492 nm wave-length
- ALT
alanin-amino-transferase
- BU
blood units
- D
dichotomization
- HBV
Hepatitis B-Virus
- HNANB
Hepatitis non-A, non-B
- OR
odds ratio
- PTH
posttransfusion hepatitis
- s/co
mean A492/cutoff= ELISA-ratio
- TPL
transplantation 相似文献
992.
Diane Purper-Ouakil Hilario Blasco-Fontecilla Tomas Ros Eric Acquaviva Tobias Banaschewski Sarah Baumeister Elisa Bousquet Aurore Bussalb Marie Delhaye Richard Delorme Renate Drechsler Allison Goujon Alexander Häge Anna Kaiser Louis Mayaud Konstantin Mechler Caroline Menache Olivier Revol Friederike Tagwerker Susanne Walitza Anna Maria Werling Stephanie Bioulac Daniel Brandeis 《Journal of child psychology and psychiatry, and allied disciplines》2022,63(2):187-198
993.
994.
995.
Zamora-Valdés D Ponciano-Rodríguez G Chávez-Tapia NC Méndez-Sánchez N 《Annals of hepatology》2005,4(4):248-254
Despite the public concern about the controversial use and abuse of marijuana, the scientific community has focused on the therapeutic potentials of cannabinoid compounds and had highlighted the importance of endocannabinoids and their receptors in physiology and disease. Endocannabinoids have been shown to be important mediators in neuroendocrine and psychiatric processes such as food intake, drug reward and energy metabolism. Cannabinoid receptors are expressed by several cell lines in the liver, such as hepatocytes, myofibroblastic cells, endothelial cells and probably cholangiocytes. A perpetuating role in liver damage for the endocannabinoid system has been proposed in several steps of chronic liver disease progression. Being a major cause of death worldwide, chronic liver disease is an important problem. New therapies are needed in order to stop or slow damage progression. This review summarizes the results of experimental studies involving the endocannabinoid system in liver disease and their clinical and therapeutical implications in hepatology. 相似文献
996.
Most of the six million Americans with fibromyalgia have at least one associated syndrome which mandates specialized attention in addition to traditional therapeutic approaches. These include localized procedures, regional blocks, antiinflammatory or antimicrobial regimens, attention to non soft tissue sources of psychosocial distress, and classes of medicines not usually prescribed for fibromyalgia. The successful treatment of fibromyalgia-associated syndromes improves the symptoms, quality of life, and prognosis of fibromyalgia. 相似文献
997.
Global outbreak of severe acute respiratory syndrome (SARS). 总被引:4,自引:0,他引:4
998.
Acute pancreatitis associated with rofecoxib 总被引:1,自引:0,他引:1
Amaravadi RK Jacobson BC Solomon DH Fischer MA 《The American journal of gastroenterology》2002,97(4):1077-1078
999.
1000.
Ross WA Ghosh S Dekovich AA Liu S Ayers GD Cleary KR Lee JH Couriel D 《The American journal of gastroenterology》2008,103(4):982-989
OBJECTIVES: The diagnosis of gastrointestinal (GI) graft- versus -host disease (GVHD) is based upon histologic findings in endoscopic mucosal biopsy specimens. The portion of the GI tract with the highest diagnostic yield is a topic of debate. Our aim was to evaluate the sensitivity of simultaneous biopsy of the stomach, duodenum, and rectosigmoid in establishing the diagnosis of GI GVHD.
METHODS: We identified 112 patients who had simultaneous endoscopic biopsies of the stomach, duodenum, and rectosigmoid within the first 100 days following allogeneic hematopoietic stem cell transplantation (HSCT). GVHD was defined histologically as the presence of gland apoptosis, not explained by other inflammatory or infectious etiologies. The patient was diagnosed with GI GVHD if at least one biopsy site was positive.
RESULTS: Overall, 81% of the patients had GI GVHD. Of these, 66% had involvement at all three biopsy sites. Rectosigmoid biopsies had the highest sensitivity, specificity, positive predictive value, and negative predictive value for diagnosing GI GVHD, at 95.6%, 100%, 100%, and 84%, respectively. The sensitivities of gastric and duodenal biopsies were 72.5% ( P < 0.0001 vs rectosigmoid) and 79.2% ( P = 0.0018), respectively. The negative predictive values of gastric and duodenal biopsies were 45.6% ( P = 0.0039 vs rectosigmoid) and 52.5% ( P = 0.0205), respectively. Rectosigmoid biopsies had a higher sensitivity and negative predictive value than biopsies at other sites whether the patient presented with diarrhea or nausea/vomiting. No association between the degree of mucosal injury and the presence of GVHD was found at any site.
CONCLUSIONS: Biopsy of the rectosigmoid is the single best test for diagnosing GI GVHD. 相似文献
METHODS: We identified 112 patients who had simultaneous endoscopic biopsies of the stomach, duodenum, and rectosigmoid within the first 100 days following allogeneic hematopoietic stem cell transplantation (HSCT). GVHD was defined histologically as the presence of gland apoptosis, not explained by other inflammatory or infectious etiologies. The patient was diagnosed with GI GVHD if at least one biopsy site was positive.
RESULTS: Overall, 81% of the patients had GI GVHD. Of these, 66% had involvement at all three biopsy sites. Rectosigmoid biopsies had the highest sensitivity, specificity, positive predictive value, and negative predictive value for diagnosing GI GVHD, at 95.6%, 100%, 100%, and 84%, respectively. The sensitivities of gastric and duodenal biopsies were 72.5% ( P < 0.0001 vs rectosigmoid) and 79.2% ( P = 0.0018), respectively. The negative predictive values of gastric and duodenal biopsies were 45.6% ( P = 0.0039 vs rectosigmoid) and 52.5% ( P = 0.0205), respectively. Rectosigmoid biopsies had a higher sensitivity and negative predictive value than biopsies at other sites whether the patient presented with diarrhea or nausea/vomiting. No association between the degree of mucosal injury and the presence of GVHD was found at any site.
CONCLUSIONS: Biopsy of the rectosigmoid is the single best test for diagnosing GI GVHD. 相似文献